Home

Gasping Long Odysseus doza GLAXO SMITH KLI... Not enough Lamb liquid

Home | GSK US
Home | GSK US

Products A-Z | GSK
Products A-Z | GSK

Glaxo to talk up 20 new vaccines
Glaxo to talk up 20 new vaccines

Therapeutic areas | GSK
Therapeutic areas | GSK

Home | GSK US
Home | GSK US

Home | GSK US
Home | GSK US

Home | GSK US
Home | GSK US

Home | GSK US
Home | GSK US

At a glance | GSK US
At a glance | GSK US

Home | GSK US
Home | GSK US

Home | GSK US
Home | GSK US

Home | GSK US
Home | GSK US

Therapeutic areas | GSK
Therapeutic areas | GSK

GSK posts middling data from PD-1 Tesaro buyout drug | Fierce Biotech
GSK posts middling data from PD-1 Tesaro buyout drug | Fierce Biotech

Home | GSK US
Home | GSK US

Shop Glaxo Smith Kline Pharmaceuticals - McKesson Medical-Surgical
Shop Glaxo Smith Kline Pharmaceuticals - McKesson Medical-Surgical

Home | GSK US
Home | GSK US

Pipeline | GSK
Pipeline | GSK

Therapeutic areas | GSK
Therapeutic areas | GSK

Research and development approach | GSK
Research and development approach | GSK

Home | GSK
Home | GSK

Home | GSK US
Home | GSK US

Shop Glaxo Smith Kline Pharmaceuticals - McKesson Medical-Surgical
Shop Glaxo Smith Kline Pharmaceuticals - McKesson Medical-Surgical

At a glance | GSK US
At a glance | GSK US

GSK plans break-up after £10bn Pfizer deal | GlaxoSmithKline | The Guardian
GSK plans break-up after £10bn Pfizer deal | GlaxoSmithKline | The Guardian

Therapeutic areas | GSK
Therapeutic areas | GSK